Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FRESENIUS KABI USA

  • FDA Approval
  • April 04, 2024, 04:34 UTC
  • 43
  • 0 comments

FDA approve NALOXONE HYDROCHLORIDE

Comment Full text

WATSON LABS

  • FDA Approval
  • April 04, 2024, 03:17 UTC
  • 43
  • 0 comments

FDA approve ALLOPURINOL

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • April 04, 2024, 03:17 UTC
  • 39
  • 0 comments

FDA approve TIPRANAVIR

Comment Full text

WATSON LABS

  • FDA Approval
  • April 04, 2024, 03:17 UTC
  • 41
  • 0 comments

FDA approve ALLOPURINOL

Comment Full text

EISAI INC

  • FDA Approval
  • April 04, 2024, 03:17 UTC
  • 33
  • 0 comments

FDA approve LENVATINIB MESYLATE

Comment Full text

UPJOHN

  • FDA Approval
  • April 04, 2024, 03:17 UTC
  • 36
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

VANDA PHARMS INC

  • FDA Approval
  • April 04, 2024, 03:17 UTC
  • 42
  • 0 comments

FDA approve ILOPERIDONE

Comment Full text

UCB INC

  • FDA Approval
  • April 04, 2024, 03:17 UTC
  • 39
  • 0 comments

FDA approve FENFLURAMINE HYDROCHLORIDE

Comment Full text

EAGLE PHARMS

  • FDA Approval
  • April 04, 2024, 03:17 UTC
  • 47
  • 0 comments

FDA approve DANTROLENE SODIUM

Comment Full text

PROVEPHARM SAS

  • FDA Approval
  • April 04, 2024, 03:17 UTC
  • 37
  • 0 comments

FDA approve TRANEXAMIC ACID

Comment Full text
  • Previous
  • 486
  • 487
  • 488
  • 489
  • 490
  • Next

Search

News categories

  • Technical Exchange News(11746)
  • Event(4165)
  • SEC News(233374)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(142859)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin